Roche investor event: AACC 2010
An Analyst briefing on Monday, July 26 to discuss Roche’s Diagnostics Division, in conjunction with the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Exposition was held in Anaheim, California (July 25–29, 2010).
- Daniel O’Day, Chief Operating Officer, Roche Diagnostics Division
- James Creeden, Head Medical Affairs, Roche Professional Diagnostics
- Paul Brown, President & CEO, Roche Molecular Diagnostics
- Hany Massarany, President Ventana Medical Systems, Head Roche Tissue Diagnostics
- Christopher McLeod, President & CEO, 454 Life Sciences, Roche Applied Science
- Karl Mahler, Head of Investor Relations